SchizophreniaHealthy VolunteersMDMA

MDMA, cannabis, and cocaine produce acute dissociative symptoms

This randomised, double-blind, placebo-controlled, four-way, cross-over study (n=37) investigated the acute dissociative effects of MDMA (25, 50, and 100 mg), cannabis (THC 21mg/70kg), and cocaine (300 mg) and compared them to data of schizophrenia patients, Special Forces soldiers, and ketamine users. Results indicate that MDMA, cannabis, and (to a lesser extent) cocaine can produce dissociative symptoms that are similar to dissociative pathology.

Authors

  • Kim Kuypers
  • Johannes Ramaekers
  • Eline Theunissen

Published

Psychiatry Research
individual Study

Abstract

Introduction

Some drugs of abuse may produce dissociative symptoms, but this aspect has been understudied. We explored the dissociative potential of three recreational drugs (3,4-methylenedioxymethamphetamine (MDMA), cannabis, and cocaine) during intoxication and compared their effects to literature reports of dissociative states in various samples.

Methods

Two placebo-controlled studies were conducted. In Study 1 (N=16), participants received single doses of 25, 50, and 100 mg of MDMA, and placebo. In Study 2 (N=21), cannabis (THC 300 µg/kg), cocaine (HCl 300 mg), and placebo were administered.

Results

Dissociative symptoms as measured with the Clinician-Administered Dissociative States Scale (CADSS) significantly increased under the influence of MDMA and cannabis. To a lesser extent, this was also true for cocaine. Dissociative symptoms following MDMA and cannabis largely exceeded those observed in schizophrenia patients, were comparable with those observed in Special Forces soldiers undergoing survival training, but were lower compared with ketamine-induced dissociation. Cocaine produced dissociative symptoms that were comparable with those observed in schizophrenia patients, but markedly less than those in Special Forces soldiers and ketamine users.

Discussion

Thus, MDMA and cannabis can produce dissociative symptoms that resemble dissociative pathology. The study of drug induced dissociation is important, because it may shed light on the mechanisms involved in dissociative psychopathology.

Available with Blossom Pro

Research Summary of 'MDMA, cannabis, and cocaine produce acute dissociative symptoms'

Introduction

Dissociative symptoms encompass a heterogeneous set of experiences ranging from absent-mindedness and excessive daydreaming to severe states such as dissociative amnesia and depersonalization/derealization disorder. These symptoms occur across a range of psychiatric diagnoses and can also appear acutely during intoxication with various drugs. Previous experimental work has shown that subanaesthetic ketamine produces depersonalization and derealization in healthy volunteers, and observational studies have linked regular MDMA and cannabis use with mild depersonalization/derealization experiences, but the dissociative potential of commonly used recreational drugs has been understudied and remains incompletely characterised. Van Heugten-Van Der Kloet and colleagues set out to explore the acute dissociative effects of three recreational drugs—MDMA, cannabis and cocaine—using placebo-controlled experimental designs. The investigators aimed to test whether these substances increase state dissociation during intoxication, whether effects are dose-dependent (for MDMA), and how drug-induced dissociation compares with dissociation reported in clinical and extreme-stress samples (schizophrenia patients, Special Forces soldiers during survival training) and with ketamine intoxication. The study therefore combined experimental drug challenges with comparisons to previously published CADSS (Clinician-Administered Dissociative States Scale) data from other samples to gauge clinical relevance.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

Cited By (4)

Papers in Blossom that reference this study

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

Ramaekers, J. G., Hutten, N. P. W., Mason, N. L. et al. · Journal of Psychopharmacology (2020)

74 cited
Key interindividual determinants in MDMA pharmacodynamics

Papaseit, E., Torrens, M., Pérez-Mañá, C. et al. · Expert Opinion on Drug Metabolism and Toxicology (2018)

MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor

Kuypers, K. P. C., Puxty, D. J., Ramaekers, J. G. et al. · Frontiers in Pharmacology (2017)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.